title: Aging and marrow neutrophil reserves.
abstract: OBJECTIVE
  Measurement of blood neutrophil (PMN) counts after the administration of hydrocortisone, granulocyte colony-stimulating factor (G-CSF) and epinephrine.
  
  
  METHODS
  Prospective study, with subjects serving as their own controls before and after administration of hydrocortisone, G-CSF, and epinephrine.
  
  
  METHODS
  The G-CSF and hydrocortisone studies were conducted at the Clinical Research Center, University of Washington, and the epinephrine study was conducted at the Seattle VA Medical Center.
  
  
  METHODS
  Healthy volunteers of both sexes (ages 20 to 30 years and 70 to 80 years) were recruited from the community. The subjects had no acute or chronic medical problems and were on no prescription medications.
  
  
  METHODS
  Change in the blood PMN count after administration of hydrocortisone (25 and 200 mg intravenously), G-CSF (30 and 300 micrograms subcutaneously), or epinephrine (10, 25, and 50 ng/kg/min intravenously).
  
  
  RESULTS
  Baseline PMN counts were similar for all comparison groups. The peak PMN response (maximum count-baseline count) to hydrocortisone was significantly less in the older subjects (P < 0.01) at both doses. The peak PMN responses were 4588 +/- 418/mm3 (25 mg) and 6906 +/- 1121/mm3 (200 mg) in the young and 1886 +/- 399/mm3 (25 mg) and 2387 +/- 372/mm3 (200 mg) in the elderly subjects. The peak PMN response following G-CSF was not different (P > 0.05) in the two groups at both the dosages: 6696 +/- 736/mm3 (30 micrograms) and 9801 +/- 893/mm3 (300 micrograms) in the young and 6340 +/- 833/mm3 (30 micrograms) and 9733 +/- 956/mm3 (300 micrograms) in the elderly. There was no age-related change in the response to epinephrine.
  
  
  CONCLUSIONS
  Aging has no effect on baseline PMN counts, bone marrow PMN reserves as measured with G-CSF, and blood PMN pools as measured with epinephrine. However the ability to mobilize these PMNs from the marrow into blood, as measured by the hydrocortisone response, is significantly reduced in the elderly.
authors.affiliation: Division of Geriatrics, University of Washington, Seattle.
authors.forename: G S
authors.initials: GS
authors.lastname: Chatta
authors.forename: T H
authors.initials: TH
authors.lastname: Price
authors.forename: J R
authors.initials: JR
authors.lastname: Stratton
authors.forename: D C
authors.initials: DC
authors.lastname: Dale
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D000375:Aging / Q000097:blood*; D001792:Blood Platelets / Q000187:drug effects; D001853:Bone Marrow / Q000187:drug effects* / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000494:pharmacology*; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology*; D006400:Hematocrit; D006801:Humans; D006854:Hydrocortisone / Q000494:pharmacology*; D007262:Infusions, Intravenous; D007279:Injections, Subcutaneous; D007958:Leukocyte Count; D008297:Male; D009504:Neutrophils / Q000187:drug effects*; D010976:Platelet Count; D011446:Prospective Studies
chemical_list: D016179:Granulocyte Colony-Stimulating Factor; D006854:Hydrocortisone; D004837:Epinephrine